Search clinical trials for: relapsed/refractory ALL
Total 468764 results
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
The Children's Hospital of Zhejiang University...College of Pharmaceutical Science at Zhejiang UniversityRecruitingAcute Myeloid Leukemia in ChildrenChina
-
Massachusetts General HospitalPfizerRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (Relapsed/Refractory)China
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruiting
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; First Affiliated Hospital Bengbu Medical... and other collaboratorsRecruiting
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; First Affiliated Hospital Bengbu Medical... and other collaboratorsRecruiting
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, India
-
Hrain Biotechnology Co., Ltd.Ruijin HospitalNot yet recruitingAcute Lymphoblastic LeukemiaChina
-
Fate TherapeuticsRecruiting
-
IRCCS Policlinico S. MatteoRecruiting
-
European Hematology Association - Lymphoma GroupAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Associazione...RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular LymphomaSpain, Netherlands, Italy, Croatia, Portugal, Ukraine
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Novartis PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic LeukemiaJapan, Canada
-
Juno Therapeutics, a Subsidiary of CelgeneAvailableLymphoma, Large B-Cell, Diffuse
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingLeukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic LeukemiaSwitzerland
-
Novartis PharmaceuticalsWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingPrimary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)United States
-
BeiGeneActive, not recruitingMature B-cell MalignanciesJapan
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteKite, A Gilead CompanyActive, not recruiting
-
University of Rome Tor VergataActive, not recruiting
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
BioNova Pharmaceuticals (Shanghai) LTD.Withdrawn
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-cell LymphomaUnited States
-
University Hospital Inselspital, BerneTerminatedAML, AdultSwitzerland
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic LeukemiaBelgium, Germany, France, Austria, Canada, Italy, Japan, Norway, Spain
-
Eureka Therapeutics Inc.Peking UniversityCompleted
-
Novartis PharmaceuticalsCompletedB-cell Acute Lymphoblastic Leukemia | Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic LeukemiaUnited States
-
Incyte Biosciences International SàrlCompletedCervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditionsUnited States
-
Beijing Tongren HospitalUnknown
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute
-
CelgeneCompletedDiffuse Large B-cell LymphomaUnited States, Australia, Italy, Spain, France, Austria, Sweden, Czechia, United Kingdom
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Lymphoma Study AssociationCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Io TherapeuticsTerminatedAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.UnknownRelapsed Non Hodgkin LymphomaChina
-
Novartis PharmaceuticalsCompletedAcute LeukemiasHungary, Belgium, Germany, Austria, Netherlands, Australia, Canada, Spain, Norway, United Kingdom, United States
-
Chinese PLA General Hospital309th Hospital of Chinese People's Liberation Army; Beijing Naval General Hospital and other collaboratorsUnknown